José Serrano

13.2k total citations · 3 hit papers
106 papers, 6.2k citations indexed

About

José Serrano is a scholar working on Epidemiology, Surgery and Pharmacology. According to data from OpenAlex, José Serrano has authored 106 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 35 papers in Surgery and 34 papers in Pharmacology. Recurrent topics in José Serrano's work include Drug-Induced Hepatotoxicity and Protection (33 papers), Pancreatitis Pathology and Treatment (23 papers) and Neuroendocrine Tumor Research Advances (21 papers). José Serrano is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (33 papers), Pancreatitis Pathology and Treatment (23 papers) and Neuroendocrine Tumor Research Advances (21 papers). José Serrano collaborates with scholars based in United States, United Kingdom and France. José Serrano's co-authors include Robert J. Fontana, Robert T. Jensen, Fathia Gibril, Herbert L. Bonkovsky, Timothy J. Davern, Paul B. Watkins, James Rochon, Stephan U. Goebel, Naga Chalasani and Leonard B. Seeff and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

José Serrano

103 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

2008 638 citations Naga Chalasani, Robert J. Fontana et al. Gastroenterology profile →
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network

2014 292 citations Victor J. Navarro, Huiman X. Barnhart et al. Hepatology profile →
Liver injury from herbal and dietary supplements

2016 286 citations Victor J. Navarro, Einar S. Björnsson et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
José Serrano United States	42	2.7k	2.5k	2.1k	1.0k	899	106	6.2k
J Domergue France	32	899 0.3×	1.2k 0.5×	1.4k 0.7×	145 0.1×	1.0k 1.2×	107	4.2k
Christian P. Strassburg Germany	59	4.5k 1.7×	2.3k 0.9×	2.2k 1.0×	225 0.2×	4.9k 5.5×	355	13.0k
Daniel J. Antoine United Kingdom	37	1.1k 0.4×	1.5k 0.6×	603 0.3×	70 0.1×	872 1.0×	75	5.6k
Adrian Reuben United States	38	2.0k 0.8×	976 0.4×	793 0.4×	52 0.1×	1.9k 2.1×	140	4.6k
Willis C. Maddrey United States	44	4.9k 1.8×	1.3k 0.5×	538 0.3×	231 0.2×	4.7k 5.3×	151	8.7k
Sheila Sherlock United Kingdom	51	2.8k 1.1×	757 0.3×	594 0.3×	162 0.2×	2.7k 3.0×	195	6.9k
Peter Angus Australia	55	5.9k 2.2×	572 0.2×	558 0.3×	148 0.1×	5.3k 5.9×	248	9.8k
R. Todd Stravitz United States	36	2.1k 0.8×	968 0.4×	939 0.4×	47 0.0×	2.2k 2.5×	59	4.3k
Philippe Lettéron France	41	2.0k 0.8×	1.1k 0.4×	383 0.2×	55 0.1×	1.0k 1.1×	71	5.0k
Bilal Hameed United States	24	4.1k 1.5×	242 0.1×	885 0.4×	234 0.2×	2.5k 2.7×	70	5.7k

Countries citing papers authored by José Serrano

Since Specialization

Citations

This map shows the geographic impact of José Serrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Serrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Serrano more than expected).

Fields of papers citing papers by José Serrano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Serrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Serrano. The network helps show where José Serrano may publish in the future.

Co-authorship network of co-authors of José Serrano

This figure shows the co-authorship network connecting the top 25 collaborators of José Serrano. A scholar is included among the top collaborators of José Serrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Serrano. José Serrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Goodarzi, Mark O., et al.. (2024). Risk and factors determining diabetes after mild, nonnecrotizing acute pancreatitis. Current Opinion in Gastroenterology. 40(5). 396–403. 2 indexed citations

2.

Yadav, Dhiraj, Dana K. Andersen, Santhi Swaroop Vege, et al.. (2024). Circulating immune signatures in chronic pancreatitis with and without preceding acute pancreatitis: A pilot study. Pancreatology. 24(3). 384–393. 3 indexed citations

3.

Lee, Bomi, Murli Manohar, Liang Li, et al.. (2023). Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study. Gastroenterology. 165(1). 173–186. 15 indexed citations

4.

Hart, Phil A., Dana K. Andersen, Santhi Swaroop Vege, et al.. (2023). Circulating immune signatures across clinical stages of chronic pancreatitis: a pilot study. European Journal of Gastroenterology & Hepatology. 36(2). 177–183. 3 indexed citations

5.

Hart, Phil A., Yogish C. Kudva, Dhiraj Yadav, et al.. (2022). A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 108(5). e120–e128. 13 indexed citations

6.

Nicoletti, Paola, Andrew Dellinger, Yi‐Ju Li, et al.. (2022). Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate. Gastroenterology. 164(3). 454–466. 25 indexed citations

7.

Dungan, Kathleen, Phil A. Hart, Dana K. Andersen, et al.. (2022). Assessing the Pathophysiology of Hyperglycemia in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study. Pancreas. 51(6). 575–579. 10 indexed citations

8.

Wani, Sachin, Rhonda F. Souza, Valerie Durkalski, et al.. (2022). Multicenter Randomized Controlled Trial of Surveillance Versus Endoscopic Therapy for Barrett’s Esophagus With Low-grade Dysplasia: The SURVENT Trial. Gastroenterology. 163(3). 556–562.e4. 3 indexed citations

9.

Cruz‐Monserrate, Zobeida, Kristyn Gumpper, Phil A. Hart, et al.. (2021). Biomarkers of Chronic Pancreatitis: A systematic literature review. Pancreatology. 21(2). 323–333. 20 indexed citations

10.

Navarro, Victor J., Huiman X. Barnhart, Herbert L. Bonkovsky, et al.. (2014). Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 60(4). 1399–1408. 292 indexed citations breakdown →

11.

Serrano, José, et al.. (2013). Valoración del riesgo cardiovascular en función de las principales variables de la hemodinámica ocular. ACTUALIDAD MEDICA. 98(789). 78–81. 1 indexed citations

12.

Davern, Timothy J., Naga Chalasani, Robert J. Fontana, et al.. (2011). Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury. Gastroenterology. 141(5). 1665–1672.e9. 243 indexed citations

13.

Fontana, Robert J., Paul B. Watkins, Herbert L. Bonkovsky, et al.. (2009). Drug-Induced Liver Injury Network (DILIN) Prospective Study. Drug Safety. 32(1). 55–68. 368 indexed citations

14.

Chalasani, Naga, Robert J. Fontana, Paul B. Watkins, et al.. (2006). Drug Induced Liver Injury Network (DILIN) Prospective Study. The American Journal of Gastroenterology. 101. S169–S169. 8 indexed citations

15.

Goebel, Stephan U., Michiko Iwamoto, Mark Raffeld, et al.. (2002). Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness.. PubMed. 62(13). 3702–10. 44 indexed citations

16.

Corleto, Vito D., Bruno Annibale, Fathia Gibril, et al.. (2001). Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger–Ellison syndrome?. Alimentary Pharmacology & Therapeutics. 15(10). 1555–1561. 55 indexed citations

17.

Serrano, José, Stephan U. Goebel, Paolo L. Peghini, et al.. (2000). Alterations in the p16^INK4a/CDKN2A Tumor Suppressor Gene in Gastrinomas. The Journal of Clinical Endocrinology & Metabolism. 85(11). 4146–4156. 98 indexed citations

18.

Goebel, Stephan U., José Serrano, Fang Yu, et al.. (1999). Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer. 85(7). 1470–1483. 54 indexed citations

19.

Goebel, Stephan U., José Serrano, Fang Yu, et al.. (1999). Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer. 85(7). 1470–1483. 2 indexed citations

20.

Norton, Jeffrey A., Douglas L. Fraker, H. Richard Alexander, et al.. (1999). Surgery to Cure the Zollinger–Ellison Syndrome. New England Journal of Medicine. 341(9). 635–644. 330 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact